for endless
Sydney - Wednesday - October 26: (RWE Aust Business News) - HealthLinx (HTX) has been granted a trademark for OvPlex in China.
This follows the announcement in September that HealthLinx has entered into a research agreement with CytogenDx Co of China to begin a 350 patient academic study as the first step to launch the OvPlex ovarian cancer diagnostic in China.
